Abstract:Objective: The aim of this study was to define the incidence and prognostic significance of venous thromboembolism (VTE) in patients with advanced, epithelial ovarian cancer undergoing frontline adjuvant chemotherapy after an extended period (28 days) of postoperative prophylaxis. Methods: A retrospective analysis of patients with advanced, epithelial ovarian cancer who underwent surgery and chemotherapy at a single institution from January 2008 through December 2011 was performed. Exclusion criteria were history of VTE, VTE during the postoperative period, clear cell histology, use of anticoagulation for a different indication, and lack of compliance with 28 days of postoperative prophylaxis with a low-molecular-weight heparin. Baseline patient demographics and oncologic outcomes were analyzed. Clinically symptomatic VTE was identified and confirmed with imaging studies. Otherwise, VTE was identified on imaging studies done to assess disease status at the conclusion of adjuvant chemotherapy. Results: One hundred twenty-eight patients met criteria for inclusion. Sixteen patients had a reported VTE during the time they were on frontline chemotherapy (12.5%). Nine patients (7%) had a pulmonary embolus, and 8 (6.3%) had a deep vein thrombus. The mean BMI in the group that developed VTE was 28, and in the group without VTE, it was 26.5 (P = 0.23). Three (23%) of the 16 patients who developed VTE had undergone a suboptimal cytoreduction compared with 12 (11%) of the 112 in the group with no VTE (P = 0.4). Six (37%) of the 16 patients who developed VTE during chemotherapy underwent a bowel resection and/or splenectomy during their cytoreductive surgery compared with 18 (16%) of the 112 patients who did not develop VTE (P = 0.079). Eight of the patients in the VTE group had indwelling venous catheters during chemotherapy (50%) compared with 39 (35%) in the group with no VTE (P = 0.27). In the group that developed VTE, there was a trend toward increased preoperative CA-125, higher rates of bowel resection and/or splenectomy during surgery, decreased use of aspirin, and inferior survival. On multivariate analysis, patients who developed VTE had significantly longer postoperative hospital stays (7 vs 5 days [P = 0.009]) and lower rates of complete response (P = 0.01). Conclusions: A 12.5% risk for VTE merits consideration of prophylaxis during chemotherapy in this cohort. A randomized, controlled trial is needed to clarify whether the benefits of long-term prophylaxis outweigh the risks and costs of such therapy.

The clinical significance of preventing venous thromboembolism of lower extremities af-ter epithelial ovarian cancer surgery

Perioperative Intervention to Prevent Lower Extremity Deep Venous Thrombosis after Gynecologic Surgery

[Prophylactic Use of Low Molecular Weight Heparin in Combination with Graduated Compression Stockings in Post-Operative Patients with Gynecologic Cancer].

Effect of Low Molecular Weight Heparin on Venous Thromboembolism Disease in Thoracotomy Patients with Cancer.

Gynecological Malignant Tumor Perioperative Venous Thrombosis Prevention Methods and Significance

Incidence and Potential Predictors of Thromboembolic Events in Epithelial Ovarian Carcinoma Patients During Perioperative Period

The analysis of the high risk factors of postoperative venous thromboembolism of gynecological cancer patients

Safety of Preoperative Heparin for Prevention of Thrombus in Patients Undergoing Thoracoscopic Surgery

Precision nursing and intermittent pneumatic compression significantly reduce perioperative deep vein thrombosis in post-surgical ovarian cancer patients

Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature

Evaluation Of Risk Factors For Venous Thromboembolism In Chinese Women With Epithelial Ovarian Cancer

Effects of Low Molecular Weight Heparin and Intermittent Pneumatic Compression on the Incidence of Deep Vein Thrombosis after Digestive Cancer Surgery

The efficacy of low molecular weight heparin in sixty cancer patients with venous thromboembolism

Effect of Low Molecular Weight Heparin Calcium on Prevention of Lower Limb Deep Venous Thrombosis in Oral Cancer Patients With Anterolateral Thigh Flap Reconstruction

Prospective analysis of pre and postoperative laboratory parameters associated with thrombosis in patients with ovarian cancer

Incidence and Risk Factors for Postoperative Venous Thromboembolism in Patients with Ovarian Cancer: Systematic Review and Meta-Analysis

Incidence and timing of venous thromboembolism after surgery for gynecological cancer

Different Combination Strategies for Prophylaxis of Venous Thromboembolism in Patients: A Prospective Multicenter Randomized Controlled Study

Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy

Preoperative laboratory parameters associated with deep vein thrombosis in patients with ovarian cancer: retrospective analysis of 3,147 patients in a single institute

Incidence and Risk Factors of Preoperative Venous Thromboembolism and Pulmonary Embolism in Patients with Ovarian Cancer.